Search - tctmd.com

Displaying 61 - 80 of 314

Sort: Relevancy | Date

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

Top General Cardiology and CVD Prevention News of 2023

Yael L. Maxwell

January 03, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Daily News

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

Todd Neale

November 20, 2023

AZALEA-TIMI 71: Abelacimab Slashes Bleeds vs Rivaroxaban in AF, but Stroke Impact Unclear

News Conference News AHA 2023

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

L.A. McKeown

November 12, 2023

News Daily News

FDA Approves Paradise Renal Denervation System: What Comes Next?

Todd Neale

November 08, 2023

News Opinion Editor's Corner AHA 2023

What’s Going to Be Hot at AHA 2023

Shelley Wood

November 07, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Conference News HFSA 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

L.A. McKeown

October 12, 2023

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Daily News

Hormonal Birth Control, NSAID Use Together Linked to VTE

Caitlin E. Cox

September 11, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2023

Caitlin E. Cox

September 04, 2023

News Conference News ESC 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

Todd Neale

August 31, 2023

News Daily News

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

L.A. McKeown

August 23, 2023

News Daily News

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

L.A. McKeown

August 22, 2023

News Opinion Editor's Corner ESC 2023

What’s Going to Be Hot at ESC 2023?

Shelley Wood

August 15, 2023

News Daily News

Women and Minorities Underrepresented in Heart Valve Trials

L.A. McKeown

July 27, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Daily News

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

L.A. McKeown

July 11, 2023

Advertisement

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

Top General Cardiology and CVD Prevention News of 2023

Top Endovascular News of 2023

Symplicity Spyral Approved: FDA Clears Second Renal Denervation System

NOW PUBLISHED - AZALEA-TIMI 71: Bleeds Plunge With Abelacimab vs Rivaroxaban in AF, but Stroke Impact Unclear

FDA Approves Paradise Renal Denervation System: What Comes Next?

What’s Going to Be Hot at AHA 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

What’s Going to Be Hot at TCT 2023

PA Pressure Monitoring Benefits HF Patients With No Recent Hospitalization

October 2023 News Roundup

Hormonal Birth Control, NSAID Use Together Linked to VTE

TCTMD’s Top 10 Most Popular Stories for August 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

Medtronic’s Renal Denervation System Fails to Sway FDA Advisory Panel

ReCor’s Renal Denervation System Gets Thumbs Up From FDA Advisory Panel

What’s Going to Be Hot at ESC 2023?

Women and Minorities Underrepresented in Heart Valve Trials

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

Popliteal Interventions Linked to Higher Long-term Amputation Risk Than SFA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content